PAR
Click for more information
4.55% 23.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Doses First US Subjects under Phase 3 trial, page-59

  1. Cabe
    9,908 Posts.
    lightbulb Created with Sketch. 225
    clock Created with Sketch.
    02/09/22
    10:42
    Post #: 63480265

    https://hotcopper.com.au/posts/63414336/single

    I should also clarify here that although the 75% chance of receiving PPS is correct, that is only in phase one of the study, in phase two the odds will only be 50/50.

    Still happy with the odds that I will get dosed in at least one of the phases - but.....

    Cheers

    Cabe
    PAR Price at posting: $1.31 Sentiment: Hold Disclosure: Not Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

WAF Drilling at Kiaka Gold Project yields 7.6 g/t intercept for West African
right-arrow Created with Sketch.
GBR Great Boulder reports mineralisation over 400m of strike at Mulga Bill North
right-arrow Created with Sketch.
NEWS Unchanged wage growth in June quarter, but public sector leaps ahead
right-arrow Created with Sketch.
NEWS Was last week's panic justified?
right-arrow Created with Sketch.
G88 Golden Mile ditches Marble Bar and Murchison tenements after weak fieldwork results
right-arrow Created with Sketch.
AVR Anteris the latest to flee a struggling ASX for Wall Street's NASDAQ
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢ 		Change
0.010(4.55%) 		Mkt cap ! $80.45M
Open High Low Value Volume
22.8¢ 23.3¢ 22.5¢ $46.92K 203.9K

Buyers (Bids)

No. Vol. Price($)
1 337 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 138166 5
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.